IGF2 and cancer: The phosphoinositide 3-kinase (PI3K)/Akt signaling pathway is involved in hypoxia-ischemia and it is a major signaling pathway in various types of cancer controlling cell survival, metastasis, and metabolism increasing the production of insulin-like growth factor 2 (IGF2) (58).